Participate in BL Poll
Satyam Q1 net up 16.5 per cent
SATYAM Computer Services Ltd has recorded total software income of Rs 1,057.81 crore (Rs 802.26 crore in Q1 last year) and a net profit of Rs 190.01 crore (Rs 163.74 crore) for the first quarter ended June 30, reflecting an increase of 35.7 per ...
`Yuan appreciation to help Indian market'
CHINA'S move to revalue its currency yuan, much below the market expectation, will have a positive impact on the Indian equity market as it will bring in more funds from FIIs and put less pressure on rising interest rates, market experts ...
2 NTC properties sold for Rs 862 cr
PRICES of Mumbai mill properties have gone through the roof, with the latest two properties on the block going for a total of Rs 862 crore. Indiabulls Real Estate Company Pvt Ltd, part of Indiabulls Financial Services, was the highest bidder at ...
Aiyar, Chidambaram discuss composition of oil firm boards
THE Petroleum Minister, Mr Mani Shankar Aiyar, today met the Finance Minister, Mr P. Chidambaram, to discuss the board composition of oil companies, particularly ONGC. The two also discussed the role of the Finance Ministry nominee on the ONGC ...
Premji enjoys housing loan subsidy!
IF you thought it was just the common man who was attracted by the low interest home loans these days, think again. Surprisingly, even the richest man in the country, the Chairman of Wipro, Mr Azim Premji, has gone in for a home loan. Mr ...
Tata Chem Q1 net up 42 pc
TATA Chemicals has reported 42 per cent increase in net profit to Rs 64.94 crore for the first quarter ended June, compared to Rs 45.64 crore in the year-ago period. Income from operations was down at Rs 509.98 crore from Rs 520.42 crore ...
GDR era returns for Indian companies
MOVE over Mumbai. Luxembourg, London, and Singapore are emerging as the preferred destinations for Indian corporates aiming to tap the financial market. And it is not by way of debt instruments alone, as ECBs and of late FCCBs are making way for ...
More global buys by pharma cos likely
IN the last 10-odd months, the Indian pharma industry has possibly seen the single largest number of global transactions in its 50-year history. But the appetite of domestic drug companies has only been whetted and more global acquisitions are ...
`Not an impressive show by new fund offers'
HERE is a pointer for those who plan to invest in new equity funds: Funds launched since the beginning of this calendar year, including the ones that clocked hefty collections, have mostly turned in indifferent performance since inception. A ...
Comments & Letters to the Editor to: firstname.lastname@example.org
Subscribe to: Business Line